Professor Dong Zhao is Deputy Director of the Beijing Institute of Heart, Lung and Blood Vessel Diseases, and Director and Professor of the Department of Epidemiology at the Institute, and at Beijing Anzhen Hospital, Capital Medical University.

Professor Zhao graduated as a medical doctor from Sun Yat-Sen Medical University of Guangzhou in China, and after her training in epidemiology at the Medicine Postgraduate Institute of Peking Union Medical College and the Institute, she worked at the School of Public Health at the University of Texas in Houston and held the position of Research Fellow at WHO and University of Texas Medical Branch in Galveston. In 2003, she received her PhD in epidemiology of cardiovascular diseases.

Professor Zhao currently serves as Vice Chair of the Chinese Society of Chronic Disease Prevention, is a member of the National Expert Committee of CVD Prevention and Treatment for the Chinese Ministry of Health, and is a board member of the Chinese Society of Cardiology and Vice Chair of the Women’s Cardiology Association. She is currently serving as Vice Chair of the Asian Pacific Association of Preventive Cardiology (2013–2015), and has been a member of the International Subcommittee for the AHA Scientific Program Committee since 2011. Professor Zhao is also a member of the Scientific and Policy Initiatives Committee of the World Heart Federation, a member of the Executive Board of the International Atherosclerosis Society, and is a member of both the working group for WHO Guidelines for CVD Multiple Risk Factor Control in Developing Countries and for the working group for China National Guidelines for the Prevention and Management of Dyslipidemia and Hypertension. Finally, Professor Zhao is a member of the Editorial Board of the Chinese Journal of Epidemiology and Chinese Journal of Cardiology, and is a board member on Nature Review Cardiology.

Academic Achievements

· In a 21-year study on CVD trends among a large, defined population in China, Professor Zhao and her team observed the long-term changing patterns of epidemics of CHD and stroke, which included a decreasing rate of the incidence of hemorrhagic stroke and increasing rates of ischemic stroke and CHD, and increasing epidemics of new metabolic risk factors in addition to uncontrolled classical risk factors. The findings highlight the importance of the prevention of ischemic CVD in the next several decades and also the necessity to consider not only hypertension but also cholesterol, obesity, diabetes and smoking among the Chinese population.

· Through a 20-year follow-up study of close to 30,000 individuals across 11 provinces of China, Professor Zhao and her team established an individualized risk assessment tool for the Chinese population. Together with her team, she also provided evidence for the establishment of clinical criteria in the diagnosis and risk stratification for hypertension, dyslipidemia and obesity, which have been adopted in several national and international guidelines.

· Based on a vast quantity of multi-dimensional data, Professor Zhao and her team established several macro-predictive models and policy models to identify quantitatively the unique patterns of CVD epidemics in different socioeconomic periods of the past, present and future, and provided scientific support for evidence-based decision-making processes for CVD primary prevention in China.

· Using a nationwide registry study, Professor Zhao and her team studied the gap between guidelines and clinical practice in China and barriers in CVD secondary prevention, and provided important information on the quality of care to provide guidance for how to reduce recurrence rates and improve quality of care.

Professor Zhao and her team have published more than 260 papers in both English and Chinese journals.

Professor Zhao has assisted in the development of three international guidelines and five national guidelines.

SCI papers published the past years

Ø Miao Wang, Andrew Moran, Jing Liu, Pamela Coxson, Paul Heidenreich, Dongfeng Gu, Jiang He, Lee Goldman,Dong Zhao .Cost-effectiveness of Improving Acute Myocardial Infarction Treatment in China: Estimation of the Coronary Heart Disease Policy Model-China. Cir Cardiovase Qual Outcomes 2014,7: 78-85

Ø Wang Y, Liu J, Wang W, Wang M, Qi Y, Xie W, Li Y, Sun J, Liu J, Zhao D. Lifetime risk for cardiovascular disease in a Chinese population: The Chinese Multi-Provincial Cohort Study. Eur J Prev Cardiol. 2013 Dec 11. doi:10.1177/2047487313516563

Ø Expert Dyslipidemia Panel, Grundy SM. An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia. J Clin Lipidol. 2013 Nov-Dec;7(6):561-5.

Ø R. Bonita, R. Magnusson, P Bovet, D Zhao et al. Country actions to meet UN commitments on non- communicable diseases: a stepwise approach.Lancet 2013, 381:575-584

Ø TO Cheng, Zhao D. Current practice on the management of acute coronary syndrome in China Inter J Cardiol 2013, 169:1-6

Ø Zhao D, Hu DY. Barriers to translating EU and US CVD guidelines into practice in China Nature Review Cardiology 2012, 9:425-429

Ø Yue Qi,… D Zhao. Association between cholesterol synthesis/absorption markers and effects of cholesterol lowering by atorvastatin among patients with high risk of coronary heart disease.J Lipid Rearch 2013, 54:3189-3197

Ø Andrew Moran, DF Gu, D Zhao et al. Future cardiovascular disease in China: Markov model and risk factor scenario projections from the CHD Policy Model-China Circulation Carduivascukar Quality and Outcomes 3 :243-252

Ø Moran AE, Oliver JT, Mirzaie M, Forouzanfar MH, Chilov M, Anderson L, Morrison JL, Khan A, Zhang N, Haynes N, Tran J, Murphy A, Degennaro V, Roth G, Zhao D, Peer N, Pichon-Riviere A, Rubinstein A, Pogosova N, Prabhakaran D, Naghavi M, Ezzati M, Mensah GA. Assessing the Global Burden of Ischemic Heart Disease: Part 1: Methods for a Systematic Review of the Global Epidemiology of Ischemic Heart Disease in 1990 and 2010. Global Heart 2012 Dec 1;7(4):315-329.

Ø Li Y, Liu J, Wang W, Yong Q, Zhou G, Wang M, Sun J, Zhao D. Association of self-reported snoring with carotid artery intima-media thickness and plaque. J Sleep Res. 2012 Feb;21(1):87-93.

Ø Zhao D, Zhao F, Li Y, Zheng Z: Projected and observed diabetes epidemics in china and beyond. Curr Cardiol Rep, 2012;14:106-111.

Ø Liu J, Wang W, Wang M, Sun J, Li Y, Qi Y, Wu Z, Zhao D: Impact of diabetes, high triglycerides and low HDL cholesterol on risk for ischemic cardiovascular disease varies by LDL cholesterol level: A 15-year follow-up of the Chinese Multi-provincial Cohort Study. Diabetes Res Clin Pract, 2012.

Ø Zhao D, Qi Y, Zheng Z, Wang Y, Zhang XY, Li HJ, Liu HH, Zhang XT, Du J, Liu J: Dietary factors associated with hypertension. Nat Rev Cardiol, 2011;8:456-465.

Ø Wang N, Zhao D, Liu J, Yu CM, Wang W, Sun J, Li Y, Du F: Impact of heart failure on in-hospital outcomes of acute coronary syndrome patients in China - Results from the Bridging the Gap on CHD Secondary Prevention in China (BRIG) project. Int J Cardiol, 2011.

Ø Qi Y, Liu J, Wang W, Wang M, Sun JY, Li Y, Wu ZS, Zhao D: The HindIII polymorphism in the lipoprotein lipase gene predicts type 2 diabetes risk among Chinese adults. Clin Chim Acta, 2011;412:1229-1233.

Ø Ren J, Grundy SM, Liu J, Wang W, Wang M, Sun J, Li Y, Wu Z, Zhao D: Long-term coronary heart disease risk associated with very-low-density lipoprotein cholesterol in Chinese: the results of a 15-Year Chinese Multi-Provincial Cohort Study (CMCS). Atherosclerosis, 2010;211:327-332.

Ø Moran A, Gu D, Zhao D, Coxson P, Wang YC, Chen CS, Liu J, Cheng J, Bibbins-Domingo K, Shen YM, He J, Goldman L: Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circ Cardiovasc Qual Outcomes, 2010;3:243-252.

Ø Niu S, Zhao D, Zhu J, Liu J, Liu Q, Wang W, Smith SC, Jr.: The association between socioeconomic status of high-risk patients with coronary heart disease and the treatment rates of evidence-based medicine for coronary heart disease secondary prevention in China: Results from the Bridging the Gap on CHD Secondary Prevention in China (BRIG) Project. Am Heart J, 2009;157:709-715 e701.

Ø Cheng J, Zhao D, Zeng Z, Critchley JA, Liu J, Wang W, Sun J, Capewell S: The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing, 1999-2010. BMC Public Health, 2009;9:30.

Ø Zhao D, Liu J, Wang W, Zeng Z, Cheng J, Sun J, Wu Z: Epidemiological transition of stroke in China: twenty- one-year observational study from the Sino-MONICA-Beijing Project. Stroke, 2008;39:1668-1674.

Ø Moran A, Zhao D, Gu D, Coxson P, Chen CS, Cheng J, Liu J, He J, Goldman L: The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China. BMC Public Health, 2008;8:394.

Ø Zhao D, Grundy SM, Wang W, Liu J, Zeng Z, Wu Z: Ten-year cardiovascular disease risk of metabolic syndrome without central obesity in middle-aged chinese. Am J Cardiol, 2007;100:835-839.

Ø Liu J, Grundy SM, Wang W, Smith SC, Jr., Vega GL, Wu Z, Zeng Z, Zhao D: Ethnic-specific criteria for the metabolic syndrome: evidence from China. Diabetes Care, 2006;29:1414-1416.

Ø Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, Newby LK, Pina IL, Roger VL, Shaw LJ, Zhao D, Beckie TM, Bushnell C, D'Armiento J, Kris-Etherton PM, Fang J, Ganiats TG, Gomes AS, Gracia CR, Haan CK, Jackson EA, Judelson DR, Kelepouris E, Lavie CJ, Moore A, Nussmeier NA, Ofili E, Oparil S, Ouyang P, Pinn VW, Sherif K, Smith SC, Jr., Sopko G, Chandra-Strobos N, Urbina EM, Vaccarino V, Wenger NK: Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation, 2011;123:1243-1262.

Ø Huffman MD, Rao KD, Pichon-Riviere A, Zhao D, Harikrishnan S, Ramaiya K, Ajay VS, Goenka S, Calcagno JI, Caporale JE, Niu S, Li Y, Liu J, Thankappan KR, Daivadanam M, van Esch J, Murphy A, Moran AE, Gaziano TA, Suhrcke M, Reddy KS, Leeder S, Prabhakaran D: A cross-sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low- and middle-income countries. PLoS One, 2011;6:e20821. One, 2011;6:e20821.

Address：E-mail: deezhao@vip.sina.com Tel：010-64456710